Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

April 3, 2017April 3, 2017

Cystic Fibrosis-related ProQR Names New Therapy Development Chief

cystic fibrosis, News

David M. Rodman is the new chief development strategy officer at ProQR Therapeutics, a leader in RNA therapies for cystic fibrosis (CF) and other diseases. Rodman, a medical doctor, will ... Read more

March 13, 2017March 13, 2017

Canon BioMedical Launches 21 Novallele Genotyping Assays for CF Analysis

cystic fibrosis, News

Canon BioMedical has developed 21 Novallele genotyping assays that can detect changes within the cystic fibrosis transmembrane conductance regulator (CFTR) — the defective gene in cystic fibrosis (CF) patients. Different types of ... Read more

March 8, 2017August 10, 2017

Vertex Acquiring Cystic Fibrosis Treatment CTP-656 from Concert Pharmaceuticals

cystic fibrosis, News

Vertex Pharmaceuticals is acquiring CTP-656, a potentiator treatment for the protein that is defective in cystic fibrosis, from Concert Pharmaceuticals. CTP-656, a deuterium-modified version of the therapy ivacaftor, is a next-generation cystic ... Read more

March 1, 2017March 1, 2017

Galapagos Doses Healthy Subject with Combo Treatment in Phase 1 CF Study

cystic fibrosis, News

Researchers conducting a Phase 1 study for cystic fibrosis (CF) have dosed their first healthy volunteer with a combination of the novel drugs GLPG2222 (a corrector) and GLPG2451 (a ... Read more

February 10, 2017February 10, 2017

Researchers Developing Mobile Respiratory Device for Children with Lung Failure

News

Researchers are developing a compact respiratory device that will allow children whose lungs have failed from cystic fibrosis (CF) or other diseases to move about a hospital rather than ... Read more

February 8, 2017February 8, 2017

Vlogs Engage and Inform People with Chronic Illnesses Like CF, Researchers Say

cystic fibrosis, News

Online vlogs — the video equivalents of web journals or blogs — can be an important platform for patients and families living with chronic diseases like cystic fibrosis (CF), a way of connecting with ... Read more

February 1, 2017February 1, 2017

CF Patients Help in Defining Top 10 Priorities for Cystic Fibrosis Research

cystic fibrosis, News

The top 10 priorities for cystic fibrosis research — set by CF patients and specialists alike — range from learning more about treatments that delay or prevent disease progression, ... Read more

January 5, 2017January 5, 2017

Phase 2 Study of Resunab in CF Patients Finished, Results Expected Soon

News

Corbus Pharmaceuticals has completed its Phase 2 clinical trial evaluating Resunab (JBT-101) for the treatment of adults with cystic fibrosis (CF), and expects to soon report topline results. “We look forward ... Read more

January 4, 2017January 4, 2017

Phase 2 Results of CFTR Potentiator Show Evidence of Comparable Efficacy to Kalydeco

News

Galapagos NV recently reported positive topline results from SAPHIRA 1, a Phase 2 clinical trial assessing the company’s potentiator molecule, GLPG1837, in patients with cystic fibrosis (CF) who have the G551D ... Read more

Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Cystic Fibrosis-related ProQR Names New Therapy Development Chief

Canon BioMedical Launches 21 Novallele Genotyping Assays for CF Analysis

Vertex Acquiring Cystic Fibrosis Treatment CTP-656 from Concert Pharmaceuticals

Galapagos Doses Healthy Subject with Combo Treatment in Phase 1 CF Study

Researchers Developing Mobile Respiratory Device for Children with Lung Failure

Vlogs Engage and Inform People with Chronic Illnesses Like CF, Researchers Say

CF Patients Help in Defining Top 10 Priorities for Cystic Fibrosis Research

Phase 2 Study of Resunab in CF Patients Finished, Results Expected Soon

Top 10 Cystic Fibrosis Articles of 2016

Phase 2 Results of CFTR Potentiator Show Evidence of Comparable Efficacy to Kalydeco

Pin It on Pinterest